Search Results - "Schnabl, Bernd"

Refine Results
  1. 1

    Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future by Lang, Sonja, Schnabl, Bernd

    Published in Cell host & microbe (12-08-2020)
    “…The liver communicates with the intestine via the portal vein, biliary system, and mediators in the circulation. Microbes in the intestine maintain liver…”
    Get full text
    Journal Article
  2. 2

    Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut by Seki, Ekihiro, Schnabl, Bernd

    Published in The Journal of physiology (01-02-2012)
    “…Liver fibrosis occurs as a wound‐healing scar response following chronic liver inflammation including alcoholic liver disease, non‐alcoholic steatohepatitis,…”
    Get full text
    Journal Article
  3. 3

    Interactions Between the Intestinal Microbiome and Liver Diseases by Schnabl, Bernd, Brenner, David A

    Published in Gastroenterology (New York, N.Y. 1943) (01-05-2014)
    “…The human intestine harbors a diverse community of microbes that promote metabolism and digestion in their symbiotic relationship with the host. Disturbance of…”
    Get full text
    Journal Article
  4. 4

    Bacteriophages and their potential for treatment of gastrointestinal diseases by Duan, Yi, Young, Ry, Schnabl, Bernd

    “…Although bacteriophages have been overshadowed as therapeutic agents by antibiotics for decades, the emergence of multidrug-resistant bacteria and a better…”
    Get full text
    Journal Article
  5. 5

    Intestinal microbiota and nonalcoholic steatohepatitis by Brandl, Katharina, Schnabl, Bernd

    Published in Current opinion in gastroenterology (01-05-2017)
    “…PURPOSE OF REVIEWNonalcoholic fatty liver disease (NAFLD) is a liver disease with high prevalence in western countries. Progression from NAFLD to nonalcoholic…”
    Get full text
    Journal Article
  6. 6

    Gut microbiome, liver immunology, and liver diseases by Wang, Rui, Tang, Ruqi, Li, Bo, Ma, Xiong, Schnabl, Bernd, Tilg, Herbert

    Published in Cellular & molecular immunology (01-01-2021)
    “…The gut microbiota is a complex and plastic consortium of microorganisms that are intricately connected with human physiology. The liver is a central…”
    Get full text
    Journal Article
  7. 7

    Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis by Bernardi, Mauro, Moreau, Richard, Angeli, Paolo, Schnabl, Bernd, Arroyo, Vicente

    Published in Journal of hepatology (01-11-2015)
    “…Summary The peripheral arterial vasodilation hypothesis has been most influential in the field of cirrhosis and its complications. It has given rise to…”
    Get full text
    Journal Article
  8. 8

    Gut mycobiome alterations and implications for liver diseases by Zeng, Suling, Schnabl, Bernd

    Published in PLoS pathogens (08-08-2024)
    “…Chronic liver disease and its complications are a significant global health burden. Changes in fungal communities (mycobiome), an integral component of the gut…”
    Get full text
    Journal Article
  9. 9

    Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk by Hartmann, Phillipp, Seebauer, Caroline T., Schnabl, Bernd

    “…Alcoholic liver disease (ALD) is a leading cause of morbidity and mortality worldwide. Alcoholic fatty liver disease can progress to steatohepatitis, alcoholic…”
    Get full text
    Journal Article
  10. 10

    Antimicrobial proteins: intestinal guards to protect against liver disease by Hendrikx, Tim, Schnabl, Bernd

    Published in Journal of gastroenterology (01-03-2019)
    “…Alterations of gut microbes play a role in the pathogenesis and progression of many disorders including liver and gastrointestinal diseases. Both qualitative…”
    Get full text
    Journal Article
  11. 11

    Immunoglobulin A and liver diseases by Inamine, Tatsuo, Schnabl, Bernd

    Published in Journal of gastroenterology (01-06-2018)
    “…Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple…”
    Get full text
    Journal Article
  12. 12

    The microbiota in cirrhosis and its role in hepatic decompensation by Trebicka, Jonel, Macnaughtan, Jane, Schnabl, Bernd, Shawcross, Debbie L., Bajaj, Jasmohan S.

    Published in Journal of hepatology (01-07-2021)
    “…Cirrhosis – the common end-stage of chronic liver disease – is associated with a cascade of events, of which intestinal bacterial overgrowth and dysbiosis are…”
    Get full text
    Journal Article
  13. 13

    Liver cirrhosis and immune dysfunction by Hasa, Elda, Hartmann, Phillipp, Schnabl, Bernd

    Published in International immunology (06-09-2022)
    “…Abstract Cirrhosis is end-stage liver disease resulting from various etiologies and is a common cause of death worldwide. The progression from compensated to…”
    Get full text
    Journal Article
  14. 14

    New mitochondrial DNA synthesis enables NLRP3 inflammasome activation by Zhong, Zhenyu, Liang, Shuang, Sanchez-Lopez, Elsa, He, Feng, Shalapour, Shabnam, Lin, Xue-jia, Wong, Jerry, Ding, Siyuan, Seki, Ekihiro, Schnabl, Bernd, Hevener, Andrea L., Greenberg, Harry B., Kisseleva, Tatiana, Karin, Michael

    Published in Nature (London) (01-08-2018)
    “…Dysregulated NLRP3 inflammasome activity results in uncontrolled inflammation, which underlies many chronic diseases. Although mitochondrial damage is needed…”
    Get full text
    Journal Article
  15. 15

    Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota by Bluemel, Sena, Williams, Brandon, Knight, Rob, Schnabl, Bernd

    “…Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) represent a major health burden in industrialized countries. Although alcohol abuse…”
    Get more information
    Journal Article
  16. 16

    Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice by Chen, Peng, Stärkel, Peter, Turner, Jerrold R., Ho, Samuel B., Schnabl, Bernd

    Published in Hepatology (Baltimore, Md.) (01-03-2015)
    “…Intestinal barrier dysfunction is an important contributor to alcoholic liver disease (ALD). Translocated microbial products trigger an inflammatory response…”
    Get full text
    Journal Article
  17. 17

    Role of the intestinal microbiome in liver fibrosis development and new treatment strategies by Zhou, Rongrong, Fan, Xuegong, Schnabl, Bernd

    “…Liver cirrhosis is a major cause of morbidity and mortality worldwide. The most common chronic liver diseases in western countries are alcohol-associated liver…”
    Get full text
    Journal Article
  18. 18

    Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice by Hendrikx, Tim, Duan, Yi, Wang, Yanhan, Oh, Jee-Hwan, Alexander, Laura M, Huang, Wendy, Stärkel, Peter, Ho, Samuel B, Gao, Bei, Fiehn, Oliver, Emond, Patrick, Sokol, Harry, van Pijkeren, Jan-Peter, Schnabl, Bernd

    Published in Gut (01-08-2019)
    “…Antimicrobial C-type lectin regenerating islet-derived 3 gamma (REG3G) is suppressed in the small intestine during chronic ethanol feeding. Our aim was to…”
    Get more information
    Journal Article
  19. 19
  20. 20

    From intestinal dysbiosis to alcohol-associated liver disease by Mendes, Beatriz Garcia, Schnabl, Bernd

    Published in Clinical and molecular hepatology (01-10-2020)
    “…Alcohol-associated intestinal dysbiosis and bacterial overgrowth can lead to a dysregulation of tryptophan metabolism and lower production of indoles. Several…”
    Get full text
    Journal Article Book Review